{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:14:42Z","timestamp":1791090882613,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["82370295"],"award-info":[{"award-number":["82370295"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Transl. Res."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12265-025-10652-9","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T23:12:22Z","timestamp":1753139542000},"page":"1243-1252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Diagnostic Significance of Circulating Eicosanoid in Patients with Hypertrophic Cardiomyopathy"],"prefix":"10.1007","volume":"18","author":[{"given":"Yue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6602-4025","authenticated-orcid":false,"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"issue":"12","key":"10652_CR1","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian C, Ingles J, Maron MS, et al. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015;65(12):1249\u201354. https:\/\/doi.org\/10.1016\/j.jacc.2015.01.019.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10652_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0735-1097(02)02020-X","volume":"40","author":"EG Abinader","year":"2002","unstructured":"Abinader EG. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40(4):837\u20138. https:\/\/doi.org\/10.1016\/S0735-1097(02)02020-X.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10652_CR3","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.3390\/jcm12103481","volume":"12","author":"R Licordari","year":"2023","unstructured":"Licordari R, Trimarchi G, Teresi L, et al. Cardiac magnetic resonance in HCM phenocopies: from diagnosis to risk stratification and therapeutic management. J Clin Med. 2023;12(10):3481. https:\/\/doi.org\/10.3390\/jcm12103481.","journal-title":"J Clin Med"},{"key":"10652_CR4","doi-asserted-by":"publisher","unstructured":"Bick AG, Flannick J, Ito K, et al. Burden of rare sarcomere gene variants in the framingham and Jackson heart study cohorts. 2012;91(3):513\u2013519.https:\/\/doi.org\/10.1016\/j.ajhg.2012.07.017.","DOI":"10.1016\/j.ajhg.2012.07.017."},{"issue":"14","key":"10652_CR5","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","volume":"138","author":"CY Ho","year":"2018","unstructured":"Ho CY, Day SM, Ashley EA, et al. Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: Insights from the sarcomeric human cardiomyopathy registry (SHaRe). Circulation. 2018;138(14):1387\u201398. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.033200.","journal-title":"Circulation"},{"issue":"5","key":"10652_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s44161-022-00057-1","volume":"1","author":"W Wang","year":"2022","unstructured":"Wang W, Wang J, Yao K, et al. Metabolic characterization of hypertrophic cardiomyopathy in human heart. Nat Cardiovasc Res. 2022;1(5):445\u201361. https:\/\/doi.org\/10.1038\/s44161-022-00057-1.","journal-title":"Nat Cardiovasc Res"},{"issue":"1","key":"10652_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk GD, Ussher JR, Folmes CDL, et al. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90(1):207\u201358. https:\/\/doi.org\/10.1152\/physrev.00015.2009.","journal-title":"Physiol Rev"},{"issue":"7986","key":"10652_CR8","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1038\/s41586-023-06755-5","volume":"623","author":"X Li","year":"2023","unstructured":"Li X, Wu F, G\u00fcnther S, et al. Publisher correction: Inhibition of fatty acid oxidation enables heart regeneration in adult mice. Nature. 2023;623(7986):E7\u2013E7. https:\/\/doi.org\/10.1038\/s41586-023-06755-5.","journal-title":"Nature"},{"key":"10652_CR9","doi-asserted-by":"publisher","unstructured":"Mason RP, Libby P, Bhatt DL. Emerging mechanisms of cardiovascular protection for the omega-3 fatty acid eicosapentaenoic acid. 2020;40(5):1135\u20131147. https:\/\/doi.org\/10.1161\/ATVBAHA.119.313286.","DOI":"10.1161\/ATVBAHA.119.313286"},{"issue":"3","key":"10652_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1042\/EBC20190083","volume":"64","author":"PC Calder","year":"2020","unstructured":"Calder PC. Eicosanoids. Essays Biochem. 2020;64(3):423\u201341. https:\/\/doi.org\/10.1042\/EBC20190083.","journal-title":"Essays Biochem"},{"issue":"3","key":"10652_CR11","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/cvr\/cvv018","volume":"105","author":"Z He","year":"2015","unstructured":"He Z, Zhang X, Chen C, et al. Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II. Cardiovasc Res. 2015;105(3):304\u201317. https:\/\/doi.org\/10.1093\/cvr\/cvv018.","journal-title":"Cardiovasc Res"},{"key":"10652_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.freeradbiomed.2018.02.009","volume":"117","author":"C Zhou","year":"2018","unstructured":"Zhou C, Huang J, Li Q, et al. CYP2J2-derived EETs attenuated ethanol-induced myocardial dysfunction through inducing autophagy and reducing apoptosis. Free Radic Biol Med. 2018;117:168\u201379. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.02.009.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10652_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s00018-024-05259-3","volume":"81","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Yuan M, Cai W, et al. Prostaglandin I2 signaling prevents angiotensin II-induced atrial remodeling and vulnerability to atrial fibrillation in mice. Cell Mol Life Sci. 2024;81(1):264. https:\/\/doi.org\/10.1007\/s00018-024-05259-3.","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"10652_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/1440-1681.13095","volume":"46","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zu L, Cai W, et al. Metabolomics revealed decreased level of omega-3 PUFA -derived protective eicosanoids in pregnant women with pre-eclampsia. Clin Exp Pharmacol Physiol. 2019;46(8):705\u201310. https:\/\/doi.org\/10.1111\/1440-1681.13095.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"10652_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.clnu.2020.05.034","volume":"40","author":"M Yuan","year":"2021","unstructured":"Yuan M, Zhang Y, Hua T, et al. Omega-3 polyunsaturated fatty acid supplementation improves lipid metabolism and endothelial function by providing a beneficial eicosanoid-pattern in patients with acute myocardial infarction: a randomized, controlled trial. Clin Nutr. 2021;40(2):445\u201359. https:\/\/doi.org\/10.1016\/j.clnu.2020.05.034.","journal-title":"Clin Nutr"},{"issue":"7","key":"10652_CR16","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCRESAHA.121.320548","volume":"130","author":"K Ma","year":"2022","unstructured":"Ma K, Yang J, Shao Y, et al. Therapeutic and prognostic significance of arachidonic acid in heart failure. Circ Res. 2022;130(7):1056\u201371. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.320548.","journal-title":"Circ Res"},{"issue":"1","key":"10652_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/1440-1681.12825","volume":"45","author":"Q Bao","year":"2018","unstructured":"Bao Q, Liu Y, Song H, et al. Spectrum evaluation-assisted eicosanoid metabolomics for global eicosanoid profiling in human vascular endothelial cells. Clin Exp Pharmacol Physiol. 2018;45(1):98\u2013108. https:\/\/doi.org\/10.1111\/1440-1681.12825.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"4","key":"10652_CR18","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1021\/pr501200u","volume":"14","author":"X Zhang","year":"2015","unstructured":"Zhang X, Yang N, Ai D, et al. Systematic metabolomic analysis of eicosanoids after omega-3 polyunsaturated fatty acid supplementation by a highly specific liquid chromatography\u2013tandem mass spectrometry-based method. J Proteome Res. 2015;14(4):1843\u201353. https:\/\/doi.org\/10.1021\/pr501200u.","journal-title":"J Proteome Res"},{"key":"10652_CR19","doi-asserted-by":"publisher","unstructured":"Pang Z, Lu Y, Zhou G, et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 2024;52(W1):W398\u2013W406. https:\/\/doi.org\/10.1093\/nar\/gkae253.","DOI":"10.1093\/nar\/gkae253"},{"issue":"11","key":"10652_CR20","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504. https:\/\/doi.org\/10.1101\/gr.1239303.","journal-title":"Genome Res"},{"issue":"1","key":"10652_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12(1):77. https:\/\/doi.org\/10.1186\/1471-2105-12-77.","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"10652_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.gene.2015.09.008","volume":"573","author":"L Carrier","year":"2015","unstructured":"Carrier L, Mearini G, Stathopoulou K, et al. Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology. Gene. 2015;573(2):188\u201397. https:\/\/doi.org\/10.1016\/j.gene.2015.09.008.","journal-title":"Gene"},{"issue":"1","key":"10652_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41569-020-0428-2","volume":"18","author":"WJ McKenna","year":"2021","unstructured":"McKenna WJ, Judge DP. Epidemiology of the inherited cardiomyopathies. Nat Rev Cardiol. 2021;18(1):22\u201336. https:\/\/doi.org\/10.1038\/s41569-020-0428-2.","journal-title":"Nat Rev Cardiol"},{"issue":"21","key":"10652_CR24","doi-asserted-by":"publisher","first-page":"12029","DOI":"10.3390\/ijms222112029","volume":"22","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Khan H, Xiao J, et al. Effects of arachidonic acid metabolites on cardiovascular health and disease. Int J Mol Sci. 2021;22(21):12029. https:\/\/doi.org\/10.3390\/ijms222112029.","journal-title":"Int J Mol Sci"},{"key":"10652_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.prostaglandins.2017.01.004","volume":"128\u2013129","author":"S Bonafini","year":"2017","unstructured":"Bonafini S. Omega-3 fatty acids and cytochrome P450-derived eicosanoids in cardiovascular diseases: Which actions and interactions modulate hemodynamics? Prostag Oth Lipid M. 2017;128\u2013129:34\u201342. https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.01.004.","journal-title":"Prostag Oth Lipid M"},{"key":"10652_CR26","doi-asserted-by":"publisher","first-page":"879209","DOI":"10.3389\/fcvm.2022.879209","volume":"9","author":"DK Sosnowski","year":"2022","unstructured":"Sosnowski DK, Jamieson KL, Darwesh AM, et al. Changes in the left ventricular eicosanoid profile in human dilated cardiomyopathy. Front Cardiovasc Med. 2022;9:879209. https:\/\/doi.org\/10.3389\/fcvm.2022.879209.","journal-title":"Front Cardiovasc Med"},{"issue":"23","key":"10652_CR27","doi-asserted-by":"publisher","first-page":"e027618","DOI":"10.1161\/JAHA.122.027618","volume":"11","author":"EL Matthia","year":"2022","unstructured":"Matthia EL, Setteducato ML, Elzeneini M, et al. Circulating biomarkers in hypertrophic cardiomyopathy. JAHA. 2022;11(23):e027618. https:\/\/doi.org\/10.1161\/JAHA.122.027618.","journal-title":"JAHA"},{"issue":"1","key":"10652_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1540-8167.2007.00965.x","volume":"19","author":"R Alcalai","year":"2008","unstructured":"Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol. 2008;19(1):104\u201310. https:\/\/doi.org\/10.1111\/j.1540-8167.2007.00965.x.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"10652_CR29","doi-asserted-by":"publisher","first-page":"13163","DOI":"10.1038\/s41598-021-89451-6","volume":"11","author":"S Vakrou","year":"2021","unstructured":"Vakrou S, Liu Y, Zhu L, et al. Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy. Sci Rep. 2021;11(1):13163. https:\/\/doi.org\/10.1038\/s41598-021-89451-6.","journal-title":"Sci Rep"},{"issue":"1","key":"10652_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s43657-022-00069-8","volume":"3","author":"L Peng","year":"2023","unstructured":"Peng L. Increased soluble epoxide hydrolase activity positively correlates with mortality in heart failure patients with preserved ejection fraction: evidence from metabolomics. Phenomics. 2023;3(1):34\u201349. https:\/\/doi.org\/10.1007\/s43657-022-00069-8.","journal-title":"Phenomics"},{"issue":"2","key":"10652_CR31","doi-asserted-by":"publisher","first-page":"e004529","DOI":"10.1161\/JAHA.116.004529","volume":"6","author":"L Zhu","year":"2017","unstructured":"Zhu L, Zou Y, Wang Y, et al. Prognostic significance of plasma high-sensitivity c-reactive protein in patients with hypertrophic cardiomyopathy. J Am Heart Assoc. 2017;6(2):e004529. https:\/\/doi.org\/10.1161\/JAHA.116.004529.","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"10652_CR32","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2217\/bmm-2019-0089","volume":"13","author":"FA Ekizler","year":"2019","unstructured":"Ekizler FA, Cay S, A\u00e7ar B, et al. Monocyte to high-density lipoprotein cholesterol ratio predicts adverse cardiac events in patients with hypertrophic cardiomyopathy. Biomark Med. 2019;13(14):1175\u201386. https:\/\/doi.org\/10.2217\/bmm-2019-0089.","journal-title":"Biomark Med"},{"issue":"13","key":"10652_CR33","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/heartjnl-2011-300960","volume":"98","author":"J Kuusisto","year":"2012","unstructured":"Kuusisto J, K\u00e4rj\u00e4 V, Sipola P, et al. Monocyte to high-density lipoprotein cholesterol ratio predicts adverse cardiac events in patients with hypertrophic cardiomyopathy. Heart. 2012;98(13):1007\u201313. https:\/\/doi.org\/10.1136\/heartjnl-2011-300960.","journal-title":"Heart"},{"issue":"4","key":"10652_CR34","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.bcp.2007.05.027","volume":"74","author":"R Altmann","year":"2007","unstructured":"Altmann R, Hausmann M, Sp\u00f6ttl T, et al. 13-Oxo-ODE is an endogenous ligand for PPAR\u03b3 in human colonic epithelial cells. Biochem Pharmacol. 2007;74(4):612\u201322. https:\/\/doi.org\/10.1016\/j.bcp.2007.05.027.","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"10652_CR35","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cardfail.2012.04.005","volume":"18","author":"F Fernandes","year":"2012","unstructured":"Fernandes F, Arteaga-Fernandez E, Antunes MDO, et al. Plasma Pro-B-Type Natriuretic Peptide testing as a screening method for hypertrophic cardiomyopathy. J Card Fail. 2012;18(7):564\u20138. https:\/\/doi.org\/10.1016\/j.cardfail.2012.04.005.","journal-title":"J Card Fail"},{"issue":"10","key":"10652_CR36","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/j.1742-1241.2009.02127.x","volume":"63","author":"D Saura","year":"2009","unstructured":"Saura D, Mar\u00edn F, Climent V, et al. Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling. Int J Clin Pract. 2009;63(10):1465\u201371. https:\/\/doi.org\/10.1111\/j.1742-1241.2009.02127.x.","journal-title":"Int J Clin Pract"},{"issue":"4","key":"10652_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jjcc.2017.02.008","volume":"70","author":"M Tesic","year":"2017","unstructured":"Tesic M, Seferovic J, Trifunovic D, et al. N-terminal pro-brain natriuretic peptide is related with coronary flow velocity reserve and diastolic dysfunction in patients with asymmetric hypertrophic cardiomyopathy. J Cardiol. 2017;70(4):323\u20138. https:\/\/doi.org\/10.1016\/j.jjcc.2017.02.008.","journal-title":"J Cardiol"},{"issue":"19","key":"10652_CR38","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1016\/j.jacc.2019.08.1057","volume":"74","author":"S Neubauer","year":"2019","unstructured":"Neubauer S, Kolm P, Ho CY, et al. Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry. J Am Coll Cardiol. 2019;74(19):2333\u201345. https:\/\/doi.org\/10.1016\/j.jacc.2019.08.1057.","journal-title":"J Am Coll Cardiol"},{"key":"10652_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.prostaglandins.2018.09.002","volume":"139","author":"X Fang","year":"2018","unstructured":"Fang X, Cai W, Cheng Q, et al. Omega-3 PUFA attenuate mice myocardial infarction injury by emerging a protective eicosanoid pattern. Prostaglandins Other Lipid Mediat. 2018;139:1\u20139. https:\/\/doi.org\/10.1016\/j.prostaglandins.2018.09.002.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10652_CR40","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1038\/s42255-024-01070-3","volume":"6","author":"T Zhou","year":"2024","unstructured":"Zhou T, Cheng J, He S, et al. The sphingosine-1-phosphate receptor 1 mediates the atheroprotective effect of eicosapentaenoic acid. Nat Metab. 2024;6:1566\u201383. https:\/\/doi.org\/10.1038\/s42255-024-01070-3.","journal-title":"Nat Metab"},{"issue":"7","key":"10652_CR41","doi-asserted-by":"publisher","first-page":"C968","DOI":"10.1152\/ajpcell.00259.2011","volume":"302","author":"S Chinthamani","year":"2012","unstructured":"Chinthamani S, Odusanwo O, Mondal N, et al. Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium. Am J Physiol Cell Physiol. 2012;302(7):C968\u201378. https:\/\/doi.org\/10.1152\/ajpcell.00259.2011.","journal-title":"Am J Physiol Cell Physiol"},{"key":"10652_CR42","doi-asserted-by":"publisher","unstructured":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(39): 2733\u20132779. https:\/\/doi.org\/10.1093\/eurheartj\/ehu284.","DOI":"10.1093\/eurheartj\/ehu284"},{"key":"10652_CR43","doi-asserted-by":"crossref","unstructured":"Wu Y, Zhang C, Dong Y, et al.. Activation of the AMP-Activated Protein Kinase by Eicosapentaenoic Acid (EPA, 20:5 n-3) improves endothelial function in vivo. PLoS One. 2012;7(4).","DOI":"10.1371\/journal.pone.0035508"},{"key":"10652_CR44","doi-asserted-by":"crossref","unstructured":"Yamagata K. Docosahexaenoic acid regulates vascular endothelial cell function and prevents cardiovascular disease. 2017.","DOI":"10.1186\/s12944-017-0514-6"},{"key":"10652_CR45","doi-asserted-by":"publisher","unstructured":"Da YO 1, Saswata T, Eun JB, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010; 142(5):687\u201398. https:\/\/doi.org\/10.1016\/j.cell.2010.07.041.","DOI":"10.1016\/j.cell.2010.07.041."}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10652-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-025-10652-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10652-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:11:42Z","timestamp":1763565102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-025-10652-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10652"],"URL":"https:\/\/doi.org\/10.1007\/s12265-025-10652-9","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The human studies were performed with the Huazhong University of Science and Technology Institutional Review Board Approval (TJ-C20181001) and abiding by the Declaration of Helsinki principles. Written informed consents were obtained from all patients and healthy volunteers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Subjects\/Informed Consent"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}